Skip to main content
Log in

Sandhoff disease in a golden retriever dog

  • Published:
Journal of Inherited Metabolic Disease

Abstract

A golden retriever dog is described with total hexosaminid ase deficiency and raised GM2-ganglioside in CSF. The animal represents a model for human Sandhoff disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  • Gravel RA, Kaback MM, Proia RL, Sandhoff K, Suzuki K, Suzuki K (2000) The GM2 gangliosidosis. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds.; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3827-3876.

    Google Scholar 

  • Ishikawa Y, Li SC, Wood PA, Li YT (1987) Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel. J Neurochem 48: 860-864.

    Google Scholar 

  • Singer HS, Cork LC (1989) Canine GM2 gangliosidosis: Morphological and biochemical analysis. Vet Pathol 26: 114-120.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. Yamato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamato, O., Matsuki, N., Satoh, H. et al. Sandhoff disease in a golden retriever dog. J Inherit Metab Dis 25, 319–320 (2002). https://doi.org/10.1023/A:1016562626961

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016562626961

Keywords

Navigation